Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03530696
Title T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer (T-DM1)
Acronym T-DM1
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Arizona
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Arizona Cancer Center Tucson Arizona 85724 United States Details
Cedar-Sinai Beverly Hills California 90048 United States Details
University of Colorado Denver Aurora Colorado 80045 United States Details
Yale Cancer Center New Haven Connecticut 06519 United States Details
Johns Hopkins Hospital Baltimore Maryland 21287 United States Details
Mosaic Life Care Saint Joseph Missouri 65406 United States Details
University of New Mexico Albuquerque New Mexico 87131 United States Details
Roswell Park Comprehensive Cancer center Buffalo New York 14263 United States Details
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Oregon Health and Sciences University Portland Oregon 97239 United States Details
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 United States Details
JPS Health Network Fort Worth Texas 76104 United States Details
Swedish Cancer Institute Seattle Washington 98104 United States Details
University of Washington Seattle Washington 98195 United States Details
University of Wisconsin Madison Wisconsin 53706 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field